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Abstract
Purpose—Most studies, primarily conducted in populations of European ancestry, reported
increased risk of head and neck cancer (HNC) associated with leanness (body mass index (BMI)
<18.5 kg/m2) and decreased for overweight or obesity (25.0-<30.0 and >30 kg/m2, respectively),
compared to normal weight (18.5-<25.0 kg/m2).
Methods—The Carolina Head and Neck Cancer Study is a population-based, racially diverse
case-control study of 1,289 incident HNC cases (330 African-Americans) and 1,361 controls (261
African-Americans). Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for
associations between BMI one year pre-diagnosis and HNC risk stratified by race and adjusted for
age, sex, smoking, alcohol, and education.
Results—Multiplicative interaction between BMI and race was evident (pint=0.00007).
Compared to normal weight, ORs for leanness were increased for African-Americans (OR=3.91,
95% CI 0.72-21.17) and whites (1.48, 0.60-3.65). For overweight and obesity, ORs were
decreased in African-Americans (0.51, 0.32-0.83 and 0.47, 0.28-0.79, respectively), but not
whites. The increased risk associated with leanness was greater for smokers than non-smokers
(pint=0.02).
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Conclusions—These data, which require replication, suggest that leanness is associated with
increased HNC risk among African-Americans to a greater extent than whites and overweight and
obesity is associated with decreased HNC risk only among African-Americans.
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Purpose
In the United States, an estimated 52,610 incident cases of oral cavity, pharynx, and larynx
cancer – collectively, head and neck cancer (HNC) – and 11,500 associated deaths will
occur in 2012 [1]. Between 2000 and 2009, the age-adjusted HNC incidence rate for
African-Americans was 12% higher than for whites (16.0 vs. 14.3 per 100,000) [2]. During
this time, the age-adjusted mortality rate of HNC for African-Americans was also 57%
higher than for whites (5.8 vs. 3.7 per 100,000) [3]. These differences were more
pronounced in males, where African-Americans have a 22% higher incidence and an 86%
higher mortality of HNC than whites [2, 3].
In North America and Europe, approximately 75% of HNC are attributed to tobacco and
alcohol consumption [4-6]. Most of the racial variation has been attributed to differences in
the prevalence of exposure to alcohol and tobacco use [7]. However, there might be other
risk factors, such as human papillomavirus (HPV) infection or socioeconomic status (SES),
which would help explain the racial disparities. A subset of HNCs, specifically cancers of
the oropharynx, has been attributed to HPV. These cancers have weaker associations with
smoking and drinking and are more likely to be African-American [8]. Additionally,
associations between cancer risk and SES vary by race [9, 10].
Body size, as measured by body mass index (BMI, kg/m2), is another factor that might
influence HNC risk and explain racial disparities. The majority of studies have found that
being underweight (<18.5 kg/m2) is associated with a higher HNC risk than normal weight
(18.5-<25.0 kg/m2). While in most studies, overweight (25.0-<30.0 kg/m2) and obesity (>30
kg/m2) are associated with a reduced HNC risk, compared to normal weight [11-20].
Conversely, a recent prospective study reported no association between BMI and HNC [21].
However, most of these studies were conducted in populations of European ancestry and did
not assess the BMI-HNC relationship among other racial groups. The Carolina Head and
Neck Cancer Study (CHANCE) is a large racially diverse population-based study that will
allow us to estimate the effects of body size by race on HNC risk.
Methods
The CHANCE study is a population-based, case-control study of incident squamous cell
carcinoma of the head and neck [22, 23]. Data were collected between January 1, 2002 and
February 28, 2006 in a 46 county region of North Carolina. Cases were aged 20-80 and
newly diagnosed with a first primary invasive squamous cell carcinoma of head and neck
cancer, including larynx (ICD-O-3 topography codes C32.0-C32.9) and pharynx and oral
cavity (C0.00-C14.8). Controls, without previous HNC diagnosis, were frequency matched
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to cases using random sampling with stratification by age, race, and sex. The study was
approved by the Institutional Review Board at the University of North Carolina at Chapel
Hill and all participating institutions.
Participant interviews consisted of a structured questionnaire that assessed demographics
and exposure to potential HNC risk factors. Participants self-reported height and weight one
year prior to diagnosis. BMI, calculated as weight in kilograms (kg) divided by height in
meters (m) squared (kg/m2), was categorized according to World Health Organization
definitions: underweight (<18.5), normal weight (18.5-24.9), overweight (25.0-29.9), and
obese (≥30.0) [24].
Individual terms for the matching factors and pairwise product terms of age [20-49
(referent), 50-54, 55-59, 60-64, 65-69, 70-74, 75-80], sex [female (referent), male], and race
[white (referent), African-American] were included in all models. Additional covariates
were determined by a directed acyclic graph and if they altered the effect estimate by ten
percent or more [25]. Confounders included in the full models were education level [high
school or less (referent), some college/vocational training, college degree/post-graduate],
duration of smoking [never use (referent), 0.5-10, 11-20, 21-30, 31-40, and 41 or more years
of cigarette smoking], and lifetime alcohol consumption [never consumed alcohol (referent)
and drinkers were divided into quartiles based on milliliters of ethanol consumption in the
controls].
Odds ratios (OR) and 95% confidence intervals (CI) for the association between BMI and
HNC risk were obtained using unconditional logistical regression and stratified by race.
Effect measure modification was evaluated by testing for deviation from a multiplicative
interaction model, using the likelihood ratio test to compare the fit of models with and
without the interaction term. The association between BMI and HNC risk by race was
evaluated by tumor site (including presumed HPV-related HNC sites [8]), smoking status,
and sex. P-values for linear trend were calculated using a continuous BMI variable. All p-
values are 2-sided and were considered statistically significant if p<0.05. In order to better
describe the relationship between BMI and risk of HNC by race, we used restricted
quadratic splines. For this analysis, the referent BMI was 21.75 (midpoint of normal weight)
and knots were set at 18.5, 25.0, and 30.0 kg/m2. Data analyses were conducted using SAS
Institute Inc. software 9.2 (Cary, NC).
Results
The eligible CHANCE study sample consisted of 1,389 cases and 1,396 controls. For this
analysis, subjects with lip cancer diagnosis (21 cases) or proxy interview (51 cases, 17
controls) were excluded. The analysis was restricted to individuals self-described as “white”
or “African-American” due to the small number of “other” race (excluding 28 cases, 18
controls). The final dataset for this analysis included 1,289 cases (959 white, 330 African-
American) and 1,361 controls (1,100 white, 261 African-American). Study characteristics
are presented in Table 1.
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Results from the analysis of BMI and HNC risk by race are presented in Table 2 (for HNC
site stratifications, see Supplemental Tables S1 and S2). A statistically-significant
multiplicative interaction between BMI and race was found [p=0.00007, χ2=21.72 (d.f.=3)].
Compared to normal weight, underweight was associated with an increased HNC risk for
whites and African-Americans (OR=1.48, 95% CI: 0.60-3.65; 3.91, 0.72-21.17,
respectively). Although the effect estimates were imprecise, the increased risk associated
with leanness was 2.6 times greater for African-Americans than whites. Among African-
Americans, overweight and obesity were associated with a decreased HNC risk (0.51,
0.32-0.83; 0.47, 0.28-0.79, respectively). However, among whites, obesity was associated
with an increased HNC risk (1.34, 1.02-1.76). The p-value for linear trend among whites
was p=0.02 and among African-Americans was p=0.01. Leanness in whites was associated
with an increased risk of presumed non-HPV-related HNC (1.61, 0.65-3.99) but not HPV-
related HNC (0.45, 0.04-4.51). Leanness in African-Americans was associated with an
increased risk of both presumed HPV-related and non-HPV-related HNC (5.64, 0.80-39.96;
4.12, 0.67-25.35, respectively), but these estimates are limited by small numbers for
African-Americans.
A statistically-significant multiplicative interaction between BMI and smoking was found
[p=0.02, χ2=10.32 (d.f.=3)]. For both whites and African-Americans, the risk, albeit
imprecise, associated with leanness was greater for smokers than non-smokers. As we would
expect, the effect estimates were similar between presumed HPV-related HNC and
nonsmokers. For both whites and African-Americans, there was no difference in the risk
associated with leanness by sex [p=0.3, χ2=4.06 (d.f.=3)].
The restricted quadratic spline graphs are presented in Figure 1 for whites and African-
Americans. The splines show a similar trend to the categorical analysis of BMI: leanness
was associated with increased risk of HNC in African-Americans and whites and overweight
and obesity was associated with decreased risk of HNC in African-Americans but not
whites.
Discussion
In this study, we determined that leanness was associated with increased overall HNC risk in
both African-Americans and whites, compared to normal weight. Although imprecise, the
effect estimate was higher in African-Americans than in whites. However, leanness was
associated with decreased HNC risk in HPV-associated sites in whites. Compared to normal
weight, a decreased HNC risk was associated with overweight and obesity in African-
Americans, but not whites.
The results of lean individuals were similar to a pooled case-control study from the
International Head and Neck Cancer Epidemiology (INHANCE) Consortium [20].
Compared to normal weight people in the study, lean individuals had an increased risk of
HNC. However, this study found a decreased HNC risk associated with overweight and
obesity, compared to normal weight [20]. These results were consistent with our findings for
African-Americans but quite different for whites, which is notable given that the INHANCE
study was 75% non-Hispanic whites. Given the difference in the minimally-adjusted and
Petrick et al. Page 4






















multivariate-adjusted estimates in our study, it is possible that we were better able to adjust
for race-specific confounding by smoking in our analyses compared to studies in the pooled
analysis. Additionally, these study differences might also be due to shifts in biased reports of
weight over time or across countries [26], but this is unclear.
In our study, the increased risk associated with leanness was greater for smokers than non-
smokers. This is similar to the INHANCE study that found ever tobacco users had greater
increased risk associated with leanness than never tobacco users [20]. The INHANCE study
also found that the decreased risk of HNC associated with overweight and obesity was
limited to tobacco users [20], which is similar to our results. Furthermore, in another
analysis of INHANCE data by Lubin et al. [27], increased risk associated with leanness was
greater for women than men for the HPV-associated site of oropharynx but not of non-HPV
related sites [27]. Our results, although not statistically significant, are consistent with this
observation.
Our results may be due to uncontrolled factors, including residual confounding by smoking,
which was the strongest confounder of the BMI-HNC relationship. However, we examined
multiple means of adjustment for smoking, including usual lifetime cigarette smoking
intensity, pack-years of cigarette smoking, and cigar and pipe smoking. We also examined
adjustment for cigarette smoking intensity and duration in the model at the same time and,
none of the adjustments resulted in materially different estimates than adjustment for
cigarette smoking duration alone. However, adjusting for smoking in the multivariate model
attenuated the results for whites more than African-Americans. Therefore, potential residual
confounding by smoking could account for some of the differences by race. The racial
differences could also be due to the fact that smoking status varies by race and BMI. For
instance, the percentage of participants that were never smokers and underweight and
normal weight among whites or African-Americans were 0.4 and 29.6%, and 1.8 and 14.9%,
respectively. In this study, African-Americans were less educated and heavier drinkers. We
explored different adjustments for these covariates in our analysis, but there is still potential
for residual confounding by these factors.
This study is the first to assess the association between leanness and HNC risk in a large,
racially diverse, population-based study. However, study limitations included self-reported
height and weight at baseline for the one year prior to diagnosis and 42.7% of cases
diagnosed at an advanced stage. Therefore, there is potential that the cases’ weights reported
for one year prior to interview might be influenced by disease symptoms. African-
Americans were also diagnosed at later stages of HNC (46.7% diagnosed at advanced stage
vs. 40.7% in whites), which may have affected their self-report of weight. However,
stratifying the estimates by stage did not yield materially different estimates. Additionally,
the INHANCE study found underweight individuals had an increased HNC risk at reference
and 2-5 years before reference (2.13, 1.75-2.58; 1.56, 0.80-3.02, respectively), but not at
20-30 years of age (0.91, 0.72-1.15) [20]. Thus, being lean over a lifetime is not associated
with HNC risk or there is misreporting of weight at ages 20-30. Finally, we are limited in
our interpretation of some estimates due to small sample size, especially for African-
Americans and underweight participants.
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In summary, we report that the associations between BMI and HNC risk vary by race, HPV-
related HNC site, and smoking. These differences may be causal or alternatively explained
by uncontrolled confounding. This is the first epidemiologic study to determine the
association between BMI and HNC risk by race; therefore, further research needs to be
conducted on the association between BMI and HNC risk before definite conclusions can be
made about racial disparities in HNC incidence and mortality in the United States.
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Restricted quadratic spline graph of the multivariate adjusteda odds ratios (represented by the solid line) and 95% confidence
intervals (represented by the dotted lines) of head and neck cancer for A) whites and B) African-Americans (case-control data
points denoted on the axes) in the Carolina Head and Neck Cancer study.
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Table 1
Characteristics of the Carolina Head and Neck Cancer (2002-2006) study subjects.









n % n % n % n %
Age (years)
    20-49 170 17.7 120 10.9 83 25.2 36 13.8
    50-54 133 13.9 113 10.3 67 20.3 47 18.0
    55-59 155 16.2 158 14.4 61 18.5 48 18.4
    60-64 164 17.1 159 14.5 53 16.1 46 17.6
    65-69 140 14.6 198 18.0 34 10.3 43 16.5
    70-74 119 12.4 204 18.5 22 6.7 23 8.8
    75-80 78 8.1 148 13.5 10 3.0 18 6.9
Sex
    Female 238 24.8 338 30.7 67 20.3 78 29.9
    Male 721 75.2 762 69.3 263 79.7 183 70.1
Education
    High School or less 508 53.0 405 36.8 290 87.9 135 51.7
    Some College 273 28.5 338 30.7 34 10.3 68 26.1
    College/post-graduate 178 18.6 357 32.5 6 1.8 58 22.2
Body Mass Index (kg/m2)
    <18.5 26 2.7 9 0.8 22 6.7 2 0.8
    18.5-24.9 327 34.1 341 31.0 157 47.7 65 25.0
    25.0-29.9 343 35.8 455 41.4 89 27.1 95 36.5
    ≥30.0 263 27.4 294 26.8 61 18.5 98 37.7
    Missing 0 1 1 1
Alcohol Consumption (ml of ethanol)
    None 111 12.3 235 22.1 10 3.3 54 21.4
    <29,036.5 83 9.2 214 20.1 8 2.6 43 17.1
    29,036.5-154,359.5 129 14.3 208 19.5 21 6.8 48 19.0
    154,359.6-488,460.0 157 17.4 213 20.0 43 14.0 45 17.9
    ≥488,460.1 420 46.7 194 18.2 225 73.3 62 24.6
    Missing 59 36 23 9
Smoking Duration (years)
    None 156 16.3 420 38.3 14 4.3 101 38.7
    0.5-10 53 5.5 124 11.3 6 1.8 25 9.6
    11-20 57 6.0 121 11.0 12 3.7 32 12.3
    21-30 121 12.6 133 12.1 70 21.3 39 14.9
    31-40 216 22.6 127 11.6 114 34.8 31 11.9
    ≥41 354 37.0 172 15.7 112 34.1 33 12.6
    Missing 2 3 2 0
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n % n % n % n %
Smoking Intensity (cigarettes/day)
    None 156 16.3 420 38.2 14 4.2 101 38.7
    1-15 113 11.8 229 20.8 98 29.7 89 34.1
    16-25 261 27.3 246 22.4 116 35.2 51 19.5
    26-35 170 17.8 82 7.5 46 13.9 14 5.4
    ≥36 256 26.8 123 11.2 56 17.0 6 2.3
    Missing 3 0 0 0
Site
    Oral Cavity 136 14.2 47 14.2
    Oropharynx 269 28.1 80 24.2
    Hypopharynx 35 3.6 24 7.3
    NOS 181 18.9 56 17.0
    Larynx 338 35.2 123 37.3
HPV Association
    HPV Site
a 254 26.5 72 21.8
    Non-HPV Site 705 73.5 258 78.2
TNM Stage
    I 230 24.0 61 18.5
    II 176 18.4 59 17.9
    III 163 17.0 56 17.0
    IVA 294 30.7 103 31.2
    IVB 92 9.6 46 13.9
    IVC 4 0.4 5 1.5
a
HNC sites that have been associated with HPV are cancers of the base on tongue, NOS; lingual tonsil; tonsil; oropharynx; and Waldeyer's ring [8].
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